b'E x e c u t i v eL e a d e r s h i p Te a mMeghna Bhatnagar, MBA, Chief Financial OfficerMeghna Bhatnagar joined Invivoscribe in 2010 as Chief Financial Officer. In this role she is responsible for leading the Invivoscribe global finance organization, along with human resources and information technology. Since her arrival, Ms. Bhatnagar has played an integral role in directing all aspects of company strategy, planning and operations.Ms. Bhatnagar has over 20 years of experience building and leading finance and IT teams in global companies. Prior to joining IVS, she served as COO of Radiant Technologies, a technology company focused on providing business management solutions to small and medium sized companies where she was responsible for leadership and development of an entire project delivery team with full P&L responsibility. She played a key role in guiding overall strategy of the company and at the same time provided leadership Meghna Bhatnagar for operational improvements.Dr. Bradley Patay, M.D., Chief Medical OfficerDr. Patay is dedicated to improving health by integrating genomic knowledge into medical care. He has authored numerous articles in this field, presented at multiple conferences and has been featured in Bloomberg Business Week. He has been head of the internal medicine section at Scripps Torrey Pines, worked as an Assistant Professor at STSI, and has been a founding member of the Board, and Vice President of the College of Genomic Medicine, which was established in 2010 to educate physicians and other health care professionals about genomic medicine.His diverse clinical experience prior to joining Scripps Clinic in 2005 includes four years as an internist and pediatrician at Neighborhood Healthcare, a private, nonprofit community healthcare practice, and at Palomar Hospital. At these institutions, Brad cared for a wide range of patients, from neonates to the elderly, Dr. Bradley Patay in both intensive care and the general wards. Through his service on several committees, he helped improve health care institutions systems.Paul McMullin, Head of Global Sales & MarketingPaul McMullin joined Invivoscribe in 2018 as the Head of Global Sales & Marketing. In this role, he leads Invivoscribes worldwide Sales and Marketing efforts with focus on both Diagnostic and Companion Diagnostics (CDx) Products. These Products are sold in over 100 Countries via a Direct Sales Organization as well as Exclusive Distributors.Mr. McMullin has over 35 years of experience working in the Medical Diagnostics Business. Most of that time has been in the molecular and biotechnology fields. His experience includes numerous positions in Sales and Marketing, establishing Direct Sales, Service and Support companies in Europe and Australia, and managing Distributor Sales in over 55 countries worldwide. He has directly managed employees in Japan, China and most major EU countries.Paul McMullin6'